How do you pay?

How to pay the least

Cash price

$740+ for 30 capsules

Pharmacies pay about this for Ongentys; you’d pay more.

  1. Ask your pharmacy for Ongentys’s cash price, and one or two other pharmacies too.
  2. Ongentys’s savings card works only with insurance from a job or one you bought.

No generic is sold yet.

Compare every option

Question
Brand nameOngentys
Authorized genericopicapone
Regular genericopicapone
What you’d pay
At least$740for 30 capsules; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Ongentys?
The original
–
–

Brand nameThe maker’s card

ONGENTYS Savings Program

Savings card from Amneal Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $25 a prescription

The card takes up to $100 a prescription off your co-pay.

Sign up on ongentys.com 

In the maker’s words

“Eligible commercially insured patients may qualify for a $25 copay on their prescriptions, applied automatically for most patients at the pharmacy through the ONGENTYS Savings Program…”

From the maker’s offer on ongentys.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Ongentys itself, from the same company, sold without the brand name, and usually for less. For now Ongentys is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

ONGENTYS is a catechol-O-methyltransferase (COMT) inhibitor indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes.

Source: the FDA label for Ongentys (Amneal Pharmaceuticals LLC), October 15, 2025. Full label on DailyMed 

Good to know